CRSP
CRISPR Therapeutics AG
Company Overview
| Mkt Cap | $5.84B | Price | $63.99 |
| Volume | 3.02M | Change | +4.73% |
| P/E Ratio | -15.9 | Open | $61.19 |
| Revenue | $37.3M | Prev Close | $61.10 |
| Net Income | $-366.3M | 52W Range | $30.04 - $78.48 |
| Div Yield | N/A | Target | $82.42 |
| Overall | 48 | Value | 60 |
| Quality | -- | Technical | 36 |
No chart data available
Stock Overview
Updated DailyCRISPR Therapeutics AG (CRSP) is a leading Healthcare company in the Biotechnology industry, currently trading at $63.99 with a market capitalization of $5.84 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CRSP with a volume of 3.02 million shares. The stock opened up 0.15% from yesterday's close of $61.10. Current analyst estimates project earnings of $-5.59 per share for this year, with next year targeting $-4.21.
CRSP demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for CRSP include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 28.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 10:54 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRSP | $63.99 | +4.7% | 3.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |